Triple Therapy
Triple Therapy is a pharmaceutical drug with 17 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.9%
10 of 11 finished
9.1%
1 ended early
2
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis
Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children
A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection
Clinical Trials (17)
Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis
Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children
A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection
Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis
Anti-inflammatory Status in DM2 Treated Patients
APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF
Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
Empirical vs Tailored Therapy for H. Pylori Infection
Impact of Periodontal Treatment on Gastric Helicobacter Pylori Eradication
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression
Ribavirin Bioavailability After Telaprevir Exposure
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy
Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication
Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens
All 17 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 17